Medicover AB engages in the provision of invitro diagnostics and healthcare services. The company is headquartered in Stockholm, Stockholm and currently employs 49,409 full-time employees. The company went IPO on 2017-05-23. The company offers a broad range of healthcare services and hub-and-spoke diagnostic laboratory network, supported by proprietary software and information systems infrastructure. The firm offers its services through two divisions: Healthcare Services and Diagnostic Services. The Healthcare Services division offers services ranging from primary care to specialist outpatient and inpatient care. The care is delivered mainly through Medicover’s own network of clinics and medical facilities. The Diagnostic Services division offers a broad range of diagnostic laboratory testing for humans and some veterinary services across all main clinical pathology specialties. The firm focuses primarily on such markets, as Poland, Germany, Romania, Ukraine.
MCVEY stock price ended at $0 on 木曜日, after dropping NaN%
On the latest trading day Jun 25, 2026, the stock price of MCVEY fell by NaN%, dropping from $NaN to $NaN. During the session, the stock saw a volatility of NaN%, with prices oscillating between a daily low of $NaN and a high of $NaN. On the latest trading day, the trading volume for MCVEY decreased by -- shares, aligning with the declining prices, which may indicate weakening market confidence in the near term. In total, -- shares were traded, with a market value of approximately --.
Comment les indicateurs d'analyse technique s'appliquent-ils à MCVEY ?
Selon l'analyse technique, Medicover AB (publ) a un signal agrégé de Neutral. Medicover AB (publ) a 0 signaux d'achat, 7 signaux neutres et 0 signaux de vente.
Quel est le RSI de Medicover AB (publ) ?
Le RSI de Medicover AB (publ) est actuellement de 0, indiquant une condition 中立
Quel est le prix de Medicover AB (publ) pour les 12 prochains mois ?
Le prix de Medicover AB (publ) MCVEY pour les 12 prochains mois est estimé à $0.
Jusqu'où Medicover AB (publ) est-il attendu?
Selon les analystes de Wall Street, Medicover AB (publ) devrait atteindre une prévision haute de $0.